Outpatient Facility Coding Alert - 2007 Issue 26
PHYSICIAN NOTES: Don't Take New ESA Coverage Limits Lying Down
Subscribe or sign in to view the full article.
Article Overview
This news-style article covers several Medicare and physician billing topics of interest to oncology practices, coders, and reimbursement staff. It discusses a revised coverage policy for erythropoiesis stimulating agents, new supplemental insurer reason codes for crossover claims, proposed changes to Quality Improvement Organization functions, a reported fraud case, and CMS guidance on reporting NPIs on the CMS-1500 claim form. The article is relevant to people monitoring Medicare policy, claims edits, and form completion changes.
Why This Topic Matters
The update touches multiple operational areas that affect reimbursement, claims handling, and compliance. It helps readers track policy changes and administrative guidance that may impact oncology billing, crossover claims, and CMS-1500 submission practices.
What You Will Learn
- What Medicare policy issues were raised concerning coverage of erythropoiesis stimulating agents
- What categories of supplemental-insurer crossover claim reason codes were announced
- What legislative proposal was discussed regarding Quality Improvement Organizations
- What CMS-1500 claim form reporting update was noted
- What broad compliance and fraud topics were mentioned in the news roundup
Who Should Read This
- Physician practice billers
- Medical coders
- Revenue cycle staff
- Oncology practices
- Compliance professionals
- Healthcare administrators
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com